Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 2713-2727

  Ribeiro Gomes, Flavia L ^a,c   Roma, Eric Henrique ^a,b   Carneiro, Matheus B H ^a,b   Doria, Nicole A ^a   Sacks, David L ^a   Peters, Nathan C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL POPULATION; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; DERMIS; DIPTERA; DOSE RESPONSE; EAR; FEMALE; FLY BITE; FOOT PAD; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INOCULATION; LEISHMANIA MAJOR; LEISHMANIASIS; MONOCYTE; MOUSE; NEEDLE; NEUTROPHIL; NONHUMAN; PARASITE LOAD; PERITONEAL CAVITY; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; BITES AND STINGS; EAR; FEMALE; FOOT; GENE EXPRESSION REGULATION; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; PERITONEAL CAVITY; PSYCHODIDAE;

EID: 84903148587     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01600-13     Document Type: Article

References (48)

1. Mahmoudzadeh-Niknam H, Khalili G, Abrishami F, Najafy A, Khaze V. 2013. The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice. Korean J. Parasitol. 51:69-74. http://dx.doi.org/10.3347/kjp.2013.51.1.69.
2. Oliveira DM, Costa MA, Chavez-Fumagalli MA, Valadares DG, Duarte MC, Costa LE, Martins VT, Gomes RF, Melo MN, Soto M, Tavares CA, Coelho EA. 2012. Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites. Parasitol. Res. 110:1277-1285. http://dx.doi.org/10.1007/s00436-011-2628-5.
3. Tabbara KS, Peters NC, Afrin F, Mendez S, Bertholet S, Belkaid Y, Sacks DL. 2005. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect. Immun. 73: 4714-4722. http://dx.doi.org/10.1128/IAI.73.8.4714-4722.2005.
4. Osorio Y, Melby PC, Pirmez C, Chandrasekar B, Guarin N, Travi BL. 2003. The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis. Parasite Immunol. 25:139-148. http://dx.doi.org/10.1046/j.1365-3024.2003.00615.x.
5. Baldwin TM, Elso C, Curtis J, Buckingham L, Handman E. 2003. The site of Leishmania major infection determines disease severity and immune responses. Infect. Immun. 71:6830-6834. http://dx.doi.org/10.1128/IAI.71.12.6830-6834.2003.
6. Menon JN, Bretscher PA. 1998. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur. J. Immunol. 28:4020-4028. http://dx.doi.org/10.1002/(SICI)1521-4141(199812)28:12<4020::AID-IMMU402 0>3.0.CO;2-3.
7. Nabors GS, Farrell JP. 1994. Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect. Immun. 62:3655-3662.
8. 1 mice infected with Leishmania major. Parasite Immunol. 17:569-579. http://dx.doi.org/10.1111/j.1365-3024.1995.tb01000.x.
9. Kirkpatrick CE, Nolan TJ, Farrell JP. 1987. Rate of Leishmaniainduced skin-lesion development in rodents depends on the site of inoculation. Parasitology 94(Part 3):451-465. http://dx.doi.org/10.1017/S0031182000055803.
10. Johnson AM. 1984. Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis. Z. Parasitenkd. 70:303-309. http://dx.doi.org/10.1007/BF00927816.
11. Vaughan JA, Scheller LF, Wirtz RA, Azad AF. 1999. Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials. Infect. Immun. 67:4285-4289.
12. Kernbauer E, Maier V, Rauch I, Muller M, Decker T. 2013. Route of infection determines the impact of type I interferons on innate immunity to Listeria monocytogenes. PLoS One 8:e65007. http://dx.doi.org/10.1371/journal.pone.0065007.
13. Wollert T, Pasche B, Rochon M, Deppenmeier S, van den Heuvel J, Gruber AD, Heinz DW, Lengeling A, Schubert WD. 2007. Extending the host range of Listeria monocytogenes by rational protein design. Cell 129: 891-902. http://dx.doi.org/10.1016/j.cell.2007.03.049.
14. Pepper M, Linehan JL, Pagán AJ, Zell T, Dileepan T, Cleary PP, Jenkins MK. 2010. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11:83-89. http://dx.doi.org/10.1038/ni.1826.
15. de Souza MS, Smith AL, Beck DS, Kim LJ, Hansen GM, Jr, Barthold SW. 1993. Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation. Infect. Immun. 61:4493-4497.
16. Yetter RA, Lehrer S, Ramphal R, Small PA, Jr. 1980. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29:654-662.
17. Bodewes R, Kreijtz JH, van Amerongen G, Hillaire ML, Vogelzang-van Trierum SE, Nieuwkoop NJ, van Run P, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2013. Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation. J. Virol. 87:4293-4301. http://dx.doi.org/10.1128/JVI.02536-12.
18. Bhowmick S, Mazumdar T, Ali N. 2009. Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect. Immun. 77:1514-1523. http://dx.doi.org/10.1128/IAI.01739-07.
19. Méndez S, Belkaid Y, Seder RA, Sacks D. 2002. Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine 20:3702-3708. http://dx.doi.org/10.1016/S0264-410X(02)00376-6.
20. Qiu J, Yan L, Chen J, Chen CY, Shen L, Letvin NL, Haynes BF, Freitag N, Rong L, Frencher JT, Huang D, Wang X, Chen ZW. 2011. Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA. Clin. Vaccine Immunol. 18:640-646. http://dx.doi.org/10.1128/CVI.00254-10.
21. Mullins DW, Sheasley SL, Ream RM, Bullock TN, Fu YX, Engelhard VH. 2003. Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J. Exp. Med. 198:1023-1034. http://dx.doi.org/10.1084/jem.20021348.
22. Lefford MJ. 1977. Induction and expression of immunity after BCG immunization. Infect. Immun. 18:646-653.
23. Lefford MJ, Warner S, Amell L. 1979. Listeria pneumonitis: influence of route of immunization on resistance to airborne infection. Infect. Immun. 25:672-679.
24. Thatte J, Rath S, Bal V. 1995. Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice. Infect. Immun. 63:99-103.
25. Mohanan D, Slutter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, Kundig TM, Gander B, Johansen P. 2010. Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems. J. Controlled Release 147:342-349. http://dx.doi.org/10.1016/j.jconrel.2010.08.012.
26. Hurpin C, Rotarioa C, Bisceglia H, Chevalier M, Tartaglia J, Erdile L. 1998. The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity. Vaccine 16:208-215. http://dx.doi.org/10.1016/S0264-410X(97)00190-4.
27. Ohlfest JR, Andersen BM, Litterman AJ, Xia J, Pennell CA, Swier LE, Salazar AM, Olin MR. 2013. Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model. J. Immunol. 190:613-620. http://dx.doi.org/10.4049/jimmunol.1201557.
28. Budimir N, de Haan A, Meijerhof T, Gostick E, Price DA, Huckriede A, Wilschut J. 2013. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration. Influenza Other Respir. Viruses 7:1202-1209. http://dx.doi.org/10.1111/irv.12142.
29. Frischknecht F. 2007. The skin as interface in the transmission of arthropod-borne pathogens. Cell. Microbiol. 9:1630-1640. http://dx.doi.org/10.1111/j.1462-5822.2007.00955.x.
30. Guilbride DL, Guilbride PD, Gawlinski P. 2012. Malaria's deadly secret: a skin stage. Trends Parasitol. 28:142-150. http://dx.doi.org/10.1016/j.pt.2012.01.002.
31. Bosio CF, Jarrett CO, Gardner D, Hinnebusch BJ. 2012. Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model. Infect. Immun. 80:4034-4045. http://dx.doi.org/10.1128/IAI.00606-12.
32. Peters NC, Sacks DL. 2009. The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis. Cell. Microbiol. 11:1290-1296. http://dx.doi.org/10.1111/j.1462-5822.2009.01348.x.
33. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, Lawyer P, Fay MP, Germain RN, Sacks D. 2008. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321:970-974. http://dx.doi.org/10.1126/science.1159194.
34. Ribeiro-Gomes FL, Peters NC, Debrabant A, Sacks DL. 2012. Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response. PLoS Pathog. 8:e1002536. http://dx.doi.org/10.1371/journal.ppat.1002536.
35. Goncalves R, Zhang X, Cohen H, Debrabant A, Mosser DM. 2011. Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J. Exp. Med. 208:1253-1265. http://dx.doi.org/10.1084/jem.20101751.
36. Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, Fay MP, Kamhawi S, Sacks D. 2008. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc. Natl. Acad. Sci. U. S. A. 105:10125-10130. http://dx.doi.org/10.1073/pnas.0802331105.
37. Sacks DL, Hieny S, Sher A. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564-569.
38. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL. 2009. Vector transmission of Leishmania abrogates vaccine-induced protective immunity. PLoS Pathog. 5:e1000484. http://dx.doi.org/10.1371/journal.ppat.1000484.
39. Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, Bortoluci KR, Almeida SR, Herzenberg LA, Herzenberg LA. 2010. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc. Natl. Acad. Sci. U. S. A. 107:2568-2573. http://dx.doi.org/10.1073/pnas.0915000107.
40. Matzinger P, Kamala T. 2011. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11:221-230. http://dx.doi.org/10.1038/nri2940.
41. Constant SL, Brogdon JL, Piggott DA, Herrick CA, Visintin I, Ruddle NH, Bottomly K. 2002. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110: 1441-1448. http://dx.doi.org/10.1172/JCI16109.
42. Peters NC, Hamilton DH, Bretscher PA. 2005. Analysis of cytokineproducing Th cells from hen egg lysozyme-immunized mice reveals large numbers specific for "cryptic" peptides and different repertoires among different Th populations. Eur. J. Immunol. 35:56-65. http://dx.doi.org/10.1002/eji.200425581.
43. Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J. 1998. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen eggwhite lysozyme (HEL) model. J. Immunol. 160:1555-1564.
44. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542. http://dx.doi.org/10.1126/science.1636090.
45. Yamakami K, Akao S, Tadakuma T, Nitta Y, Miyazaki J, Yoshizawa N. 2002. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major. Immunology 105:515-523. http://dx.doi.org/10.1046/j.1365-2567.2002.01394.x.
46. Uzonna JE, Wei G, Yurkowski D, Bretscher P. 2001. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167:6967-6974. http://dx.doi.org/10.4049/jimmunol.167.12.6967.
47. Stamper LW, Patrick RL, Fay MP, Lawyer PG, Elnaiem DE, Secundino N, Debrabant A, Sacks DL, Peters NC. 2011. Infection parameters in the sand fly vector that predict transmission of Leishmania major. PLoS Negl. Trop. Dis. 5:e1288. http://dx.doi.org/10.1371/journal.pntd.0001288.
48. Lira R, Doherty M, Modi G, Sacks D. 2000. Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high-and low-dose challenge with Leishmania major. Infect. Immun. 68:5176-5182. http://dx.doi.org/10.1128/IAI.68.9.5176-5182.2000.